ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD – Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 10,720,000 ...
Radiopharmaceuticals company Telix Pharmaceuticals has provided its Q4 FY24 trading update, showing sustained revenue growth.
Acadia Pharmaceuticals ACAD announced that it has submitted a marketing authorization application (MAA) to the European ...
The Department of Justice (DOJ) recouped more than $2.9 billion for the federal government from False Claims Act settlements ...